Medline Recalls Over 3.5 Million Units of Sterile Saline Wound Wash Due to Sterility Concerns

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries, LP has issued a voluntary recall for all lots of its Sterile Saline Wound Wash after identifying that the product may not meet required sterility assurance levels.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevice.

What Happened

Medline Industries, LP has initiated a voluntary Class II recall of its Sterile Saline Wound Wash. The company identified that the manufacturer of the product may not have adhered to the minimum sterility assurance levels required for products labeled as sterile. This defect was identified during an ongoing quality review process.

Which Products Are Affected

The recall affects approximately 3,578,805 units of the following product:

  • Product Name: Medline Sterile Saline Wound Wash, Cleansing & Wound Irrigation, USP Normal Saline (0.9% Sodium Chloride)
  • Size: 7.1 FL OZ (210 mL)
  • Model Number: MDSALINE7
  • UDI-DI: 10193489089356 (individual unit); 20193489089353 (case)
  • Affected Lots: All Lots
  • Recall Number: Z-1431-2026

The products were distributed nationwide across the United States and internationally to the Bahamas, Bermuda, and the Cayman Islands.

What You Should Do

Consumers, healthcare facilities, and distributors should immediately stop using and distributing all lots of the Medline Sterile Saline Wound Wash (Model MDSALINE7). Medline notified customers of this recall via a formal letter initiated on January 5, 2026. For information regarding product returns or further guidance, consumers may contact Medline Industries, LP at their headquarters in Northfield, Illinois.

Why This Matters

The use of a wound irrigation product that fails to meet sterility standards can introduce contaminants into open wounds, potentially leading to infections or other adverse health complications for patients.

Source

Information provided by the FDA (Recall Event ID: 98319).

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries, LP has issued a voluntary recall for all lots of its Sterile Saline Wound Wash after identifying that the product may not meet required sterility assurance levels.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.